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A 47-year-old Hispanic woman presented to the 
emergency department for evaluation of a left frontal head 
mass she reported noticing in the previous month, which 
caused her localized dull discomfort. She denied any recent or 
past trauma, and denied any vision, speech, motor or sensory 
changes. Her examination was significant for a large, firm, 
non-tender exophytic left frontal mass, approximately 5 cm 
in diameter with normal scalp overlying it. Her neurological 
examination was completely normal. An MRI revealed a 
10x6x4 cm area of expansion of the left frontal and parietal 
calvarium with a plaque-like dural based mass underlying 
the calvarial thickening, consistent with a meningioma with 
interosseous extension. There was moderate mass effect on the 
underlying left cerebral hemisphere with a 5mm midline shift 
to the right (Figure 1).
Meningiomas are one of the most frequently reported 
primary intracranial neoplasm, accounting for approximately 
25% of all such lesions diagnosed in the United States.1 The 
incidence increases with age and is higher in women, with a 
male-to-female ratio of about 1:2.2 While the majority (>90%) 
of meningiomas are histopathologically benign, they can be 
associated with devastating neurological complications, such 
as seizures and vision loss.3 The risk factors most commonly 
attributed to meningiomas are exposure to ionizing radiation 
and hormones, although the exact association between these 
has not been clearly defined.1 The options for management and 
prognosis of benign meningiomas are dictated primarily by 
tumor location and size. Surgery is the mainstay of treatment 
but given that these are slow-growing tumors and sometimes 
asymptomatic, it is not necessary for every patient. Other 
options include radiation alone or as an adjuvant to surgery, or 
observation.4
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Figure 1. Moderate mass effect with 5mm midline shift to the right 
on the underlying left cerebral hemisphere.